EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis

Sangmi Oh iD, Helena I M Boshoff iD, Jose Santinni O Roma, Aidan Boving, Danielle M Weiner, April Walker, Laura E Via iD, Clifton E Barry iD

ACS Infectious Diseases · 10.07.2026 · 12 (7) · 2372-2382

DOI: 10.1021/acsinfecdis.6c00340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 09.06.2026. Verfasst von Sangmi Oh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), Nat…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Prodrugs, Antitubercular Agents, Indoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill & Melinda Gates Foundation, Intramural NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indole 4-carboxamides are promising prodrugs that liberate 4-aminoindole, which poisons tryptophan biosynthesis in Mycobacterium tuberculosis (Mtb). Limiting enthusiasm for these compounds is the high rate of emergence of resistance since the amidase, which liberates the 4-aminoindole core, is nonessential. To overcome this limitation, we designed bifunctional β-lactams that, upon hydrolytic opening of the β-lactam ring, liberate 4-aminoindole. These bifunctional molecules had good potency against Mtb, which could be rescued by exogenous l-tryptophan addition. In contrast to the parental indole 4-carboxamides, resistant mutants to these bifunctional compounds developed at a much lower frequency than the parental compounds in vitro, supporting this strategy as a means to protect these agents from rapid development of resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisProdrugsAntitubercular AgentsIndolesCephalosporinsMicrobial Sensitivity TestsTryptophan

Stichwörter der Autor:innen

4-aminoindoleantitubercular activitycephalosporinsprodrugstryptophan biosynthesistuberculosis

Substanzen

ProdrugsAntitubercular AgentsIndolesCephalosporinsTryptophan

Autor:innen und Institutionen

  • Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, United Sta…
  • Tuberculosis Imaging Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, United States.

ORCID-Profile: Sangmi Oh, Helena I M Boshoff, Laura E Via, Clifton E Barry

Förderung

  • Bill & Melinda Gates Foundation
  • Intramural NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Oh, S., Boshoff, H. I. M., Roma, J. S. O., Boving, A., Weiner, D. M., Walker, A., Via, L. E., & Barry, C. E. (2026). Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis. ACS Infectious Diseases, 12(7), 2372-2382. https://doi.org/10.1021/acsinfecdis.6c00340

Vancouver

Oh S, Boshoff HIM, Roma JSO, Boving A, Weiner DM, Walker A, et al. Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis. ACS Infectious Diseases. 2026;12(7):2372-2382. doi:10.1021/acsinfecdis.6c00340

BibTeX
@article{Oh2026,
  author = {Oh, Sangmi and Boshoff, Helena I M and Roma, Jose Santinni O and Boving, Aidan and Weiner, Danielle M and Walker, April and Via, Laura E and Barry, Clifton E},
  title = {Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {2372--2382},
  doi = {10.1021/acsinfecdis.6c00340}
}
Kostenlos starten →